Search results for "Mycose"

showing 10 items of 351 documents

Israeli Spotted FeverRickettsiain SicilianRhipicephalus sanguineusTicks

2003

To the Editor: Mediterranean spotted fever (MSF) is endemic in Italy, where it is a reportable disease. From 1992 to 1998, the Italian Ministry of Health was notified of approximately 8,500 cases of human rickettsioses presumed to be MSF. MSF occurs more commonly in some central (Lazio) and southern (Sardinia, Sicily, and Calabria) regions (1,2); in 1998, an average of 8.8 cases occurred for every 100,000 persons in Sicily, compared with the national average of 1.6 cases per 100,000 persons. Rickettsia conorii has been thought to be the only pathogenic Rickettsia of the spotted fever group in Sicily (3,4) or the western Mediterranean area. Recently, three different spotted fever group ricke…

Microbiology (medical)Ixodes ricinusEpidemiologyRhipicephalus sanguineusMolecular Sequence Datalcsh:MedicineTicklcsh:Infectious and parasitic diseasesSerologyTicksAnimalslcsh:RC109-216RickettsiaLetters to the Editorbiologylcsh:RRickettsia Infectionsbacterial infections and mycosesbiology.organism_classificationVirologylanguage.human_languageSpotted feverInfectious DiseasesRickettsiaItalylanguageArachnid VectorsRickettsia conoriiSicilianBacterial Outer Membrane ProteinsEmerging Infectious Diseases
researchProduct

Identification of Three Clinically Relevant Borrelia burgdorferi Sensu Lato Genospecies by PCR-Restriction Fragment Length Polymorphism Analysis of 1…

2004

ABSTRACT We report the results of a study of the prevalences of three clinically relevant Borrelia burgdorferi sensu lato genospecies ( Borrelia burgdorferi sensu stricto, Borrelia afzelii , and Borrelia garinii ) in 1,040 questing Ixodes ticks from all regions of Latvia, where Lyme borreliosis is endemic. The prevalences of Borrelia in Ixodes ricinus and Ixodes persulcatus were 22.6 and 27.9%, respectively. Molecular typing of B. burgdorferi from infected ticks was performed by restriction fragment length polymorphism (RFLP) analysis of PCR-amplified fragments of the 16S-23S ( rrs-rrlA ) rRNA intergenic spacer by using species-specific primers and subsequent sequencing. The dominant Borrel…

Microbiology (medical)Ixodes ricinusGenotypeMolecular Sequence DataIxodes persulcatusBorrelia afzeliimedicine.disease_causePolymerase Chain ReactionBorrelia burgdorferi GroupRNA Ribosomal 16SBorreliaparasitic diseasesDNA Ribosomal SpacermedicineAnimalsBorrelia burgdorferiLyme DiseaseIxodesbiologyBacteriologySequence Analysis DNAbacterial infections and mycosesbiology.organism_classificationLatviaVirologyRNA Ribosomal 23SLyme disease microbiologyIxodesBorrelia gariniiPolymorphism Restriction Fragment LengthJournal of Clinical Microbiology
researchProduct

Recent Advances on the Innate Immune Response to Coxiella burnetii.

2021

Coxiella burnetii is an obligate intracellular Gram-negative bacterium and the causative agent of a worldwide zoonosis known as Q fever. The pathogen invades monocytes and macrophages, replicating within acidic phagolysosomes and evading host defenses through different immune evasion strategies that are mainly associated with the structure of its lipopolysaccharide. The main transmission routes are aerosols and ingestion of fomites from infected animals. The innate immune system provides the first host defense against the microorganism, and it is crucial to direct the infection towards a self-limiting respiratory disease or the chronic form. This review reports the advances in understanding…

Microbiology (medical)LipopolysaccharidesImmunologyexperimental modelcytokine—immunological termsQ feverimmunotherapeuticReviewMicrobiologyMicrobiologyImmune systemCellular and Infection MicrobiologyToll-like receptorinflammasomeautophagiamedicineAnimalsHumansPathogeninnate immunityInnate immune systemObligatebiologyTransmission (medicine)MacrophagesInflammasomeCoxiella burnetiibiology.organism_classificationmedicine.diseasebacterial infections and mycosesImmunity InnateQR1-502Toll-like receptorsimmunotherapeuticsInfectious DiseasesCoxiella burnetiibacteriaQ Fevercytokine—immunological termmedicine.drug
researchProduct

Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.

1990

The efficacy and safety of ceftazidime and imipenem in patients with severe infections was compared in a randomized multi-centre trial. Patients on assisted respiration with clinical signs of pneumonia or septicaemia who had been in hospital for at least 3 days were studied. Twenty-one patients were treated with ceftazidime, 24 with imipenem. The mean duration of treatment was 9 days in both groups. At the end of the trial 17 patients (81%) of the ceftazidime group and 16 patients (67%) in the imipenem group were clinically cured or showed marked improvement. The bacteriological results showed an eradication of the causative pathogens in 17 of 21 cases in the ceftazidime group and 13 of 19 …

Microbiology (medical)Malemedicine.medical_specialtyImipenemCeftazidimeHospital-acquired pneumoniaCeftazidimeInternal medicineSepsismedicineHumansMulticenter Studies as TopicIn patientRandomized Controlled Trials as TopicCross Infectionbusiness.industryImipenem/cilastatinGermany WestGeneral MedicinePneumoniaMiddle Agedbacterial infections and mycosesmedicine.diseaseRespiration ArtificialSurgeryClinical trialPneumoniaDrug CombinationsImipenemInfectious DiseasesCilastatinFemalebusinessmedicine.drugThe Journal of hospital infection
researchProduct

MRSA infection in the neonatal intensive care unit

2013

Methicillin-resistant Staphylococcus aureus (MRSA) is well known as one of the most frequent etiological agents of healthcare-associated infections. The epidemiology of MRSA is evolving with emergence of community-associated MRSA, the clonal spread of some successful clones, their spillover into healthcare settings and acquisition of antibacterial drug resistances. Neonatal intensive care unit (NICU) patients are at an especially high risk of acquiring colonization and infection by MRSA. Epidemiology of MRSA in NICU can be very complex because outbreaks can overlap endemic circulation and make it difficult to trace transmission routes. Moreover, increasing prevalence of community-associated…

Microbiology (medical)Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtyNeonatal intensive care unitMRSA infectionSettore MED/42 - Igiene Generale E ApplicataMicrobiologySettore MED/38 - Pediatria Generale E SpecialisticaVirologyIntensive Care Units NeonatalEpidemiologymedicinePrevalenceInfection controlHumansIntensive care medicineAntibacterial drugDeveloping CountriesInfection Controlbusiness.industryTransmission (medicine)Developed CountriesAustraliaInfant NewbornMRSA CA-MRSA HA-MRSA NICU epidemiology prevention controlOutbreakbiochemical phenomena metabolism and nutritionStaphylococcal Infectionsbacterial infections and mycosesUnited StatesAnti-Bacterial AgentsEuropeInfectious DiseasesEpidemiological MonitoringEpidemiological Monitoringbusiness
researchProduct

Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a fle…

2012

ABSTRACT We report here that modifications of the preanalytical steps of matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) identification of yeasts, with regard to the original protocol provided by the manufacturers, appear to be efficient for the reliable routine identification of clinical yeast isolates in medical laboratories. Indeed, when one colony was sampled instead of five and the protein extraction protocol was modified, the performance of MALDI-TOF MS was superior to that of the API ID 32C method (discrepancies were confirmed by using molecular identification), allowing the correct identification of 94% of the 335 clinical isolates prospec…

Microbiology (medical)Microbiological TechniquesTime Factorsmedical laboratories[SDV]Life Sciences [q-bio]clinical yeast isolatesMatrix assisted laser desorption ionization time of flightMycologyMass spectrometrySpecimen Handlingflight mass spectrometry03 medical and health sciencesYeastsHumansionization-time030304 developmental biologyMolecular identification0303 health sciencesChromatography030306 microbiologyChemistryYeastCulture MediaIdentification (information)Mycosesmatrix-assisted laserSpectrometry Mass Matrix-Assisted Laser Desorption-Ionization[SDE]Environmental SciencesidentificationJournal of clinical microbiology
researchProduct

vacA Genotypes and Genetic Diversity in Clinical Isolates of Helicobacter pylori

1998

ABSTRACT Genetic diversity in Helicobacter pylori strains may affect the function and antigenicity of virulence factors associated with bacterial infection and, ultimately, disease outcome. In this study, DNA diversity of H. pylori isolates was examined by analysis of vacA genotypes and by restriction fragment length polymorphism (RFLP) analysis of H. pylori -associated genes ( vacA , cagA , flaA , ureAB , and ureCD ). Thirty-seven H. pylori isolates from 26 patients were successfully classified into distinct vacA allelic genotypes. The signal sequence allele s1 (31 of 37) predominated over the s2 allele (6 of 37) and was significantly associated with the occurrence (past or present) of gas…

Microbiology (medical)Molecular Sequence DataClinical BiochemistryImmunologyArticleMicrobiologyNucleotide diversityBacterial ProteinsGenetic variationGenotypeHumansImmunology and AllergyCagAAmino Acid SequenceAlleleGeneticsGenetic diversityBase SequenceHelicobacter pyloribiologyGenetic VariationHelicobacter pyloribacterial infections and mycosesbiology.organism_classificationdigestive system diseasesGenes BacterialRestriction fragment length polymorphismClinical Diagnostic Laboratory Immunology
researchProduct

ESAT-6 Peptide Recognition by Bovine CD8 + Lymphocytes of Naturally Infected Cows in Herds from Southern Italy

2006

ABSTRACT The aim of this study was to define epitopes of Mycobacterium bovis from ESAT-6 (early secretory antigen of 6 kDa) recognized by CD8 + T lymphocytes from cows naturally infected with Mycobacterium bovis . We found that bovine CD8 + T cells recognized 10 out of 11 ESAT-6 peptides tested.

Microbiology (medical)Molecular Sequence DataClinical BiochemistryImmunologyEpitopes T-LymphocytePeptideCD8-Positive T-LymphocytesTUBERCULOSISDIAGNOSISLymphocyte Activationcomplex mixturesANTIGENSVeterinary ImmunologyEpitopeMicrobiologyInterferon-gammaMiceBacterial ProteinsAntigenmedicineAnimalsImmunology and AllergyInterferon gammaAmino Acid SequenceMACROPHAGESSicilyPeptide sequenceCells CulturedMYCOBACTERIUM-BOVISchemistry.chemical_classificationAntigens BacterialMycobacterium bovisbiologybacterial infections and mycosesbiology.organism_classificationMycobacterium bovisVirologychemistryESAT-6VACCINATIONCattleFemaleTuberculosis BovineCD8medicine.drugClinical and Vaccine Immunology
researchProduct

In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii

2005

To compare the activity of linezolid with a range of drugs used in the treatment of Mycobacterium kansasii infections.The percentages of resistant isolates against isoniazid, rifampicin and ethambutol were 2.9%, 1.9% and 2.9%, respectively. All isolates were susceptible to clarithromycin and moxifloxacin both with MIC(90) values of 0.125 mg/L. Linezolid was active against all isolates with MIC(50) and MIC(90) values of 0.5 and 1 mg/L, respectively, both below the susceptibility breakpoint established for mycobacteria.Linezolid, clarithromycin or moxifloxacin, could be used as alternative drugs for treatment of infections due to rifampicin-resistant isolates as well as short-course or interm…

Microbiology (medical)MoxifloxacinMicrobial Sensitivity TestsBiologyMicrobiologychemistry.chemical_compoundMoxifloxacinClarithromycinClarithromycinAcetamidesDrug Resistance Bacterialpolycyclic compoundsmedicineHumansheterocyclic compoundsPharmacology (medical)OxazolidinonesEthambutolAntibacterial agentPharmacologyMycobacterium kansasiiAza CompoundsIsoniazidLinezolidbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationAnti-Bacterial AgentsInfectious DiseaseschemistryMycobacterium kansasiiLinezolidQuinolinesbacteriaRifampicinFluoroquinolonesmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-…

2004

Background: Recently an increase in the number of invasive Haemophilus influenzae type b (Hib) cases was observed in the United Kingdom, which coincided with a temporary change from diphtheria-tetanus toxoids-wild-type pertussis to diphtheria-tetanus toxoids-acellular pertussis (DTaP) Hib vaccines. A study in Germany based on approximately 2 years of follow-up, estimated vaccine effectiveness (VE) of DTaP/Hib and DTaP-inactivated poliovirus/Hib combination vaccines against invasive Hib disease to be high. Objectives: To assess VE of DTaP-containing Hib vaccines against Hib in Germany with the use of extended follow-up of case surveillance and vaccine uptake. Subjects and Methods: Cases with…

Microbiology (medical)Pediatricsmedicine.medical_specialtyHaemophilus InfectionsBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinesmedicine.disease_causecomplex mixturesHaemophilus influenzaeCohort StudiesGermanymedicineHumansVaccines CombinedWhooping coughHaemophilus VaccinesRetrospective Studiesbusiness.industryTetanusDiphtheriaPoliovirusHaemophilus influenzae type bToxoidInfantbacterial infections and mycosesmedicine.diseaseVirologyPoliovirus VaccinesInfectious DiseasesCase-Control StudiesChild PreschoolPediatrics Perinatology and Child HealthEnterovirusbusinessPediatric Infectious Disease Journal
researchProduct